About one third of people with continuous positive airway pressure (CPAP) devices and masks treat sleep apnoea are not obesity related. About one third of people use the devices are severely obese, so even 25% of weight reduction may not help them to come off the devices. About one third of people use the devices are just overweight, and it is likely they no longer need to use the devices in the future, should they keep weights down or keep on GLP-1weight-loss drugs.
RMD Price at posting:
$22.86 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)